Latest Ratios: P/E Ratio 9.0x · EV/EBITDA 13.5x · ROE 18.5%. (1995–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $364M | $733M | $988M | $899M | $1.0B | $1.0B | $1.1B | $1.3B | $1.1B | $1.2B | $1.2B |
| Enterprise Value | $302M | $671M | $943M | $861M | $943M | $974M | $1.1B | $1.2B | $1.1B | $1.1B | $1.1B |
| P/E Ratio → | 8.98 | 15.55 | 17.83 | 14.48 | 18.05 | 15.88 | 12.85 | 13.76 | 15.28 | 25.67 | 15.40 |
| P/S Ratio | 1.09 | 2.31 | 3.19 | 2.93 | 3.41 | 3.31 | 3.28 | 3.45 | 2.90 | 3.16 | 3.02 |
| P/B Ratio | 1.47 | 2.91 | 3.84 | 3.08 | 3.16 | 2.62 | 2.53 | 2.97 | 2.67 | 2.79 | 2.62 |
| P/FCF | 29.50 | 82.15 | 42.29 | 30.71 | 38.47 | 28.48 | 17.80 | 16.40 | 11.26 | 9.10 | 10.64 |
| P/OCF | 32.85 | 66.21 | 40.82 | 30.14 | 35.62 | 27.51 | 17.54 | 16.19 | 11.13 | 9.06 | 10.48 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.12 | 3.05 | 2.80 | 3.20 | 3.08 | 3.09 | 3.33 | 2.79 | 3.01 | 2.87 |
| EV / EBITDA | 13.48 | 11.26 | 13.45 | 10.92 | 13.67 | 12.11 | 9.73 | 10.58 | 11.89 | 13.58 | 9.99 |
| EV / EBIT | 5.13 | 11.40 | 13.66 | — | 13.94 | 12.26 | 9.82 | 10.67 | 12.03 | 13.74 | 10.09 |
| EV / FCF | — | 75.21 | 40.41 | 29.39 | 36.11 | 26.55 | 16.81 | 15.84 | 10.84 | 8.67 | 10.11 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.4% | 46.4% | 41.4% | 44.1% | 48.3% | 49.1% | 100.0% | 45.6% | 38.8% | 37.6% | 43.2% |
| Operating Margin | 18.6% | 18.6% | 22.3% | 25.2% | 23.0% | 25.1% | 31.5% | 31.2% | 23.2% | 21.9% | 28.4% |
| Net Profit Margin | 14.9% | 14.9% | 17.9% | 20.2% | 18.9% | 20.8% | 25.5% | 25.0% | 19.0% | 12.3% | 19.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 18.5% | 18.5% | 20.2% | 20.4% | 15.5% | 15.7% | 19.9% | 22.1% | 17.2% | 10.5% | 17.1% |
| ROA | 4.1% | 4.1% | 4.6% | 5.0% | 4.2% | 4.7% | 6.2% | 6.5% | 5.0% | 3.2% | 5.4% |
| ROIC | 21.9% | 21.9% | 22.2% | 22.8% | 17.4% | 16.9% | 21.0% | 22.9% | 17.8% | 16.1% | 21.6% |
| ROCE | 13.0% | 13.0% | 13.6% | 14.6% | 12.0% | 13.4% | 7.6% | 8.1% | 6.1% | 5.7% | 7.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.25 | -0.17 | -0.13 | -0.19 | -0.18 | -0.14 | -0.10 | -0.10 | -0.13 | -0.13 |
| Net Debt / EBITDA | -1.04 | -1.04 | -0.63 | -0.49 | -0.89 | -0.88 | -0.57 | -0.38 | -0.46 | -0.67 | -0.52 |
| Debt / FCF | — | -6.94 | -1.89 | -1.32 | -2.35 | -1.93 | -0.99 | -0.56 | -0.42 | -0.43 | -0.52 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($62M) exceeds total debt ($0)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.61 | 0.61 | 0.59 | 0.59 | 0.87 | 0.92 | — | — | — | — | — |
| Quick Ratio | 0.61 | 0.61 | 0.59 | 0.59 | 0.87 | 0.92 | — | — | — | — | — |
| Cash Ratio | 0.21 | 0.21 | 0.19 | 0.19 | 0.53 | 0.59 | — | — | — | — | — |
| Asset Turnover | — | 0.28 | 0.27 | 0.25 | 0.23 | 0.23 | 0.25 | 0.26 | 0.27 | 0.26 | 0.27 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 13.1% | 6.6% | 8.7% | 10.4% | 10.0% | 2.2% | 8.0% | 6.8% | 7.7% | 7.0% | 6.4% |
| Payout Ratio | 103.1% | 103.1% | 154.1% | 150.2% | 180.6% | 34.2% | 102.5% | 93.9% | 118.0% | 178.8% | 97.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 11.1% | 6.4% | 5.6% | 6.9% | 5.5% | 6.3% | 7.8% | 7.3% | 6.5% | 3.9% | 6.5% |
| FCF Yield | 3.4% | 1.2% | 2.4% | 3.3% | 2.6% | 3.5% | 5.6% | 6.1% | 8.9% | 11.0% | 9.4% |
| Buyback Yield | 3.3% | 1.7% | 0.6% | 0.2% | 1.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 16.4% | 8.3% | 9.2% | 10.6% | 11.2% | 2.2% | 8.0% | 6.8% | 7.7% | 7.0% | 6.4% |
| Shares Outstanding | — | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AMSF stock.
AMERISAFE, Inc.'s current P/E ratio is 9.0x. The historical average is 14.4x. This places it at the 15th percentile of its historical range.
AMERISAFE, Inc.'s current EV/EBITDA is 13.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.4x.
AMERISAFE, Inc.'s return on equity (ROE) is 18.5%. The historical average is 22.6%.
Based on historical data, AMERISAFE, Inc. is trading at a P/E of 9.0x. This is at the 15th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
AMERISAFE, Inc.'s current dividend yield is 13.10% with a payout ratio of 103.1%.
AMERISAFE, Inc. has 46.4% gross margin and 18.6% operating margin. Operating margin between 10-20% is typical for established companies.
Key Metrics
Top Statement Risk
Loss ratio volatility from claims
Metrics are mathematically derived from official filings.
Discount to Book Reflects Earnings Doubt
Based on reported figures, AMSF trades at a P/B of 1.49 and a trailing P/E of 7.93, a multiple that implies the market is pricing in a sustained ROE near the 3-5% range seen across recent quarters rather than a premium franchise return.
The P/B of 1.49 sits modestly above the Employers Holdings figure of 1.19 but well below Arch Capital's 1.67, which the peer group indicates is where investors price insurers that generate ROE in the high teens. The trailing P/E of 7.93 looks inexpensive, yet it is applied to earnings that have swung sharply with quarterly loss ratios, so the multiple may be flattering a cyclical peak rather than a durable run-rate. Investors should monitor whether the forward P/E of 10.45 signals expected margin normalization or simply reflects reduced near-term earnings.
Combined Ratio Swings Above and Below Breakeven
Reported combined ratios ranged from 77.3% to 111.0% over ten quarters, with the 2026Q2 spike driven by a 136.6% loss ratio that pushed the book into underwriting loss and highlighted claims as the dominant profitability variable.
The 2026Q2 combined ratio of 111.0% and the 2026Q3 reading of 88.7% show that underwriting results remain highly sensitive to a small number of adverse claims quarters. The expense ratio figures are internally inconsistent, including negative values in 2026Q2, so the expense trend cannot be read cleanly and warrants further investigation before drawing efficiency conclusions. Sustained combined ratios below 90% would suggest the underwriting franchise is recovering, while repeated readings near or above 100% would suggest pricing or reserving adequacy is under pressure.
ROE Depends on Thin Underwriting Margins
As reported in the supplied financial statements, AMSF's ROE has ranged from 3.0% to 5.9% and ROA from 0.6% to 1.3%, with investment income contribution not disclosed in the data, leaving the decomposition between underwriting and float returns data unavailable.
With ROE clustered in a narrow low-single-digit band, the return on equity offers little cushion if underwriting margins compress, and the lack of investment income detail prevents separating underwriting profit from float yield. The fact that ROA is roughly one-fifth of ROE reflects the substantial leverage inherent in the insurance balance sheet, which amplifies small changes in margins. Investors should monitor whether reported returns can be sustained without relying on reserve releases, which the data does not allow us to assess.
Shrinking Equity Base Tightens Capital Cushion
Based on reported figures, AMSF's equity declined roughly 24.5% from $314.4M in 2024Q3 to $237.3M in 2026Q3, while premium-to-surplus leverage cannot be measured because premium-volume detail is not populated in the supplied data.
A shrinking equity base amid repeated capital returns suggests the surplus supporting premium writings is being reduced faster than it is rebuilt, which narrows underwriting capacity. Without reported net written premium, the premium-to-surplus ratio is data unavailable and any rating agency comparison would be speculative. The contraction in equity-to-assets from roughly 26% toward 21% may indicate a thinner buffer against adverse development, which warrants further investigation.
Misapplied Metric: Single-Quarter Combined Ratio
The combined ratio most often misapplied to AMSF is a single-quarter reading, which can mislead because the 2026Q2 spike to 111.0% and the 77.3% low in 2024Q4 show quarterly claims timing dominates the figure, obscuring the underlying trend.
Using one quarter's combined ratio to judge underwriting quality ignores reserve development and claims timing, both of which can swing results substantially in a workers' compensation book. A better approach would be a trailing twelve-month or multi-year average combined ratio, adjusted for prior-year reserve development where disclosed. Based on reported figures, the ten-quarter range is wide enough that conclusions drawn from any single period should be treated as provisional.